网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
血及尿DKK3在造影剂所致急性肾损伤中的预测价值
作者:孙泽源1  鄢高亮2  王栋2  乔勇2  汤成春2 
单位:1. 东南大学 医学院, 江苏 南京 210009;
2. 东南大学附属中大医院 心血管内科, 江苏 南京 210009
关键词:Dickkopf相关蛋白3 造影剂 急性肾损伤 
分类号:R692
出版年·卷·期(页码):2022·50·第六期(672-676)
摘要:

目的:探讨外周血及尿液中Dickkopf相关蛋白3(DKK3)对冠脉造影术后造影剂诱导的急性肾损伤(CI-AKI)的预测价值。方法:纳入2019年8月至2021年8月在东南大学附属中大医院行冠脉造影和经皮冠脉介入治疗(PCI)的患者466例,根据患者冠脉造影前后的血肌酐水平评估患者是否发生CI-AKI。采用ELISA法检测患者血及尿液中DKK3含量,单因素及多因素Logistic回归分析筛选CI-AKI的危险因素,受试者工作特征(ROC)曲线评估DDK3对CI-AKI的诊断价值。结果:466例患者中共有35例发生CI-AKI,发生率为7.5%。CI-AKI患者血DDK3和尿DKK3/尿肌酐值均高于非CI-AKI患者(均P<0.05)。Logistic回归分析结果显示尿DKK3/尿肌酐值是CI-AKI的独立危险因素(OR=3.24,95%CI 2.61~4.92)。ROC曲线分析显示尿DKK3/尿肌酐值预测CI-AKI的曲线下面积(AUC)是0.659(95%CI 0.544~0.775,P=0.002)。结论:CI-AKI患者血DKK3和尿DKK3/尿肌酐值较未发生CI-AKI患者显著增加,尿DKK3/尿肌酐值对冠脉造影术后发生CI-AKI有良好的预测价值。

Objective: To investigate the predictive value of serum and urinary Dickkopf-related protein 3(DKK3) on contrast-induced acute kidney injury(CI-AKI) after coronary angiography. Methods: This study included 466 patients who underwent coronary angiography and percutaneous coronary intervention(PCI) from August 2019 to August 2021 in Zhongda Hospital Affiliated to Southeast University. Serum and urinary DKK3 levels were measured by ELISA. Univariate and multivariate logistic regression analysis were performed to identify the risk factors for CI-AKI. The predictive value of DDK3 for CI-AKI was assessed by receiver operating characteristic(ROC) curve analysis. Results: A total of 35(7.5%) in 466 patients developed CI-AKI after coronary angiography and PCI. The serum DKK3 and urinary DKK3/urinary creatinine ratio in patients with CI-AKI were higher than those in patients without CI-AKI(all P<0.05). Logistic regression analysis showed urinary DKK3/urinary creatinine ratio was an independent risk factor for CI-AKI(OR=3.24, 95% CI 2.61~4.92). ROC curve analysis showed that the area under the curve(AUC) of urinary DKK3/urinary creatinine ratio for predicting CI-AKI was 0.659(95%CI 0.544~0.775, P=0.002). Conclusion: Serum DKK3 and urinary DKK3/urinary creatinine ratio were significantly increased in patients with CI-AKI compared to those without CI-AKI, and urinary DKK3/urinary creatinine ratio has good predictive value on the occurrence of CI-AKI after coronary angiography.

参考文献:

[1] KOOIMAN J,SETH M,NALLAMOTHU B K,et al.Association between acute kidney injury and in-hospital mortality in patients undergoing percutaneous coronary interventions[J].Circ Cardiovasc Interv,2015,8(6):e002212.
[2] 唐庚,马根山.造影剂肾病防治的研究进展[J].现代医学,2017,45(11):1691-1695.
[3] ZHANG W F,ZHANG T,DING D,et al.Use of both serum cystatin c and creatinine as diagnostic criteria for contrast-induced acute kidney injury and its clinical implications[J].J Am Heart Assoc,2017,6(1):e004747.
[4] NIEHRS C.Function and biological roles of the Dickkopf family of Wnt modulators[J].Oncogene,2006,25(57):7469-7481.
[5] LIU Q W,LI J Y,ZHANG X C,et al.Human amniotic mesenchymal stem cells inhibit hepatocellular carcinoma in tumour-bearing mice[J].J Cell Mol Med,2020,24(18):10525-10541.
[6] LEVIN A,TONELLI M,BONVENTRE J,et al.Global kidney health 2017 and beyond:a roadmap for closing gaps in care,research,and policy[J].Lancet,2017,390(10105):1888-1917.
[7] ZEWINGER S,RAUEN T,RUDNICKI M,et al.Dickkopf-3(DKK3) in urine identifies patients with short-term risk of eGFR loss[J].J Am Soc Nephrol,2018,29(11):2722-2733.
[8] SCHUNK S J,ZARBOCK A,MEERSCH M,et al.Association between urinary dickkopf-3,acute kidney injury,and subsequent loss of kidney function in patients undergoing cardiac surgery:an observational cohort study[J].Lancet,2019,394(10197):488-496.
[9] KELLUM J A,LAMEIRE N.Diagnosis,evaluation,and management of acute kidney injury:a KDIGO summary (Part 1)[J].Critical Care,2013,17(1):204.
[10] MURRAY P T,MEHTA R L,SHAW A,et al.Potential use of biomarkers in acute kidney injury:report and summary of recommendations from the 10th acute dialysis quality initiative consensus conference[J].Kidney Int,2014,85(3):513-521.
[11] BRIGUORI C,VISCONTI G,RIVERA N V,et al.Cystatin C and contrast-induced acute kidney injury[J].Circulation,2010,121(19):2117-2122.
[12] QUINTAVALLE C,ANSELMI C V,DE MICCO F,et al.Neutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injury[J].Circ Cardiovasc Interv,2015,8(9):e002673.
[13] PARIKH C R,LIU C,MOR M K,et al.Kidney biomarkers of injury and repair as predictors of contrast-associated AKI:a substudy of the PRESERVE trial[J].Am J Kidney Dis,2020,75(2):187-194.
[14] NELSON P J,VON TOERNE C,GRÖNE H J.Wnt-signaling pathways in progressive renal fibrosis[J].Expert Opin Ther Targets,2011,15(9):1073-1083.
[15] 许为佳,李涛,费沛,等.DKK3在慢性肾小球肾炎中表达及诱导肾小球足细胞迁移的机制研究[J].临床肾脏病杂志,2019,19(3):181-186.
[16] PIEK A,SMIT L,SUTHAHAR N,et al.The emerging plasma biomarker Dickkopf-3(DKK3) and its association with renal and cardiovascular disease in the general population[J].Sci Rep,2021,11(1):8642.
[17] NUSSE R,CLEVERS H.Wnt/β-catenin signaling,disease,and emerging therapeutic modalities[J].Cell,2017,169(6):985-999.
[18] LIPPHARDT M,DIHAZI H,JEON N L,et al.Dickkopf-3 in aberrant endothelial secretome triggers renal fibroblast activation and endothelial-mesenchymal transition[J].Nephrol Dial Transplant,2019,34(1):49-62.
[19] FEDERICO G,MEISTER M,MATHOW D,et al.Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis[J].JCI Insight,2016,1(1):e84916.
[20] FANG X,HU J,CHEN Y,et al.Dickkopf-3:Current Knowledge in Kidney Diseases[J].Front Physiol,2020,11:533344.
[21] SÁNCHEZ-ÁLAMO B,GARCÍA-IÑIGO F J,SHABAKA A,et al.Urinary Dickkopf-3:a new biomarker for CKD progression and mortality[J].Nephrol Dial Transplant,2021,36(12):2199-2207.
[22] ROSCIGNO G,QUINTAVALLE C,BIONDI-ZOCCAI G,et al.Urinary Dickkopf-3 and contrast-associated kidney damage[J].J Am Coll Cardiol,2021,77(21):2667-2676.
[23] SEIBERT F S,HERINGHAUS A,PAGONAS N,et al.Dickkopf-3 in the prediction of contrast media induced acute kidney injury[J].J Nephrol,2021,34(3):821-828.
[24] ALMENDAREZ M,GURM HS,MARIANI J,et al.Procedural strategies to reduce the incidence of contrast-induced acute kidney injury during percutaneous coronary intervention[J].JACC Cardiovasc Interv,2019,12(19):1877-1888.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 751391 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541